Wolfgang SCHMIDT

Person

Saffron Walden, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds having muscarinic receptor antagonist and beta2 adrenergi...
- Patent number 10,196,386
- Issue date Feb 5, 2019
- CHIESI FARMACEUTICI S.P.A.
- Fabio Rancati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having muscarinic receptor antagonist and BETA2 adrenergi...
- Patent number 10,004,728
- Issue date Jun 26, 2018
- CHIESI FARMACEUTICI S.P.A.
- Fabio Rancati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having muscarinic receptor antagonist and beta2 adrenergi...
- Patent number 9,662,323
- Issue date May 30, 2017
- CHIESI FARMACEUTICI S.P.A.
- Laura Carzaniga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having muscarinic receptor antagonist and BETA2 adrenergi...
- Patent number 9,579,314
- Issue date Feb 28, 2017
- CHIESI FARMACEUTICI S.P.A.
- Fabio Rancati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having muscarinic receptor antagonist and beta2 adrenergi...
- Patent number 9,453,013
- Issue date Sep 27, 2016
- CHIESI FARMACEUTICI S.P.A.
- Fabio Rancati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrazine compounds useful for the treatment of degenerative a...
- Patent number 9,006,237
- Issue date Apr 14, 2015
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolopyrazine compounds useful for the treatment of degenerativ...
- Patent number 8,178,530
- Issue date May 15, 2012
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolopyrazine compounds useful for the treatment of degenerativ...
- Patent number 8,173,656
- Issue date May 8, 2012
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine compounds useful for the treatment of degenerative a...
- Patent number 8,148,369
- Issue date Apr 3, 2012
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine compounds useful for the treatment of degenerative a...
- Patent number 8,138,193
- Issue date Mar 20, 2012
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine compounds useful for the treatment of degenerative a...
- Patent number 8,133,895
- Issue date Mar 13, 2012
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridine compounds useful for the treatment of degenerative...
- Patent number 7,977,352
- Issue date Jul 12, 2011
- Galapagos N.V.
- Paul John Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrazine compounds useful for the treatment of degenerative...
- Patent number 7,915,256
- Issue date Mar 29, 2011
- Galapagos N.V.
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolopyrazine compounds useful for the treatment of degenerativ...
- Patent number 7,893,058
- Issue date Feb 22, 2011
- JANSSEN PHARMACEUTICA NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrazine compounds useful for the treatment of degenerative...
- Patent number 7,501,411
- Issue date Mar 10, 2009
- Galapagos, NV
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20230150980
- Publication date May 18, 2023
- ANIMA BIOTECH INC.
- David William SHEPPARD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20230116201
- Publication date Apr 13, 2023
- ANIMA BIOTECH INC.
- David William SHEPPARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20180016267
- Publication date Jan 18, 2018
- Chiesi Farmaceutici s.p.A.
- Fabio RANCATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20170119753
- Publication date May 4, 2017
- Chiesi Farmaceutici s.p.A.
- Fabio RANCATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20160346271
- Publication date Dec 1, 2016
- Chiesi Farmaceutici s.p.A.
- Laura CARZANIGA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20160235734
- Publication date Aug 18, 2016
- Chiesi Farmaceutici s.p.A.
- Fabio RANCATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20150139916
- Publication date May 21, 2015
- Chiesi Farmaceutici s.p.A.
- Fabio RANCATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...
- Publication number 20140163066
- Publication date Jun 12, 2014
- Chiesi Farmaceutici s.p.A.
- Fabio RANCATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused Pyrazine Compounds Useful for the Treatment of Degenerative a...
- Publication number 20120232075
- Publication date Sep 13, 2012
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIV...
- Publication number 20110218178
- Publication date Sep 8, 2011
- Janssen Pharmaceutica N.V.
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE...
- Publication number 20110178067
- Publication date Jul 21, 2011
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIV...
- Publication number 20110092497
- Publication date Apr 21, 2011
- Janssen Pharmaceutica N.V.
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE...
- Publication number 20100298300
- Publication date Nov 25, 2010
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE A...
- Publication number 20100240666
- Publication date Sep 23, 2010
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused pyrazine compounds useful for the treatment of degenerative a...
- Publication number 20090131446
- Publication date May 21, 2009
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triazolopyridine compounds useful for the treatment of degenerative...
- Publication number 20090105242
- Publication date Apr 23, 2009
- Paul John Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused pyrazine compounds useful for the treatment of degenerative a...
- Publication number 20090012078
- Publication date Jan 8, 2009
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triazolopyrazine compounds useful for the treatment of degenerative...
- Publication number 20080090818
- Publication date Apr 17, 2008
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolopyrazine compounds useful for the treatment of degenerativ...
- Publication number 20070281943
- Publication date Dec 6, 2007
- Martin James Inglis Andrews
- C07 - ORGANIC CHEMISTRY

Wolfgang SCHMIDT

Person

Patents Grantslast 30 patents

Compounds having muscarinic receptor antagonist and beta2 adrenergi...

Compounds having muscarinic receptor antagonist and BETA2 adrenergi...

Compounds having muscarinic receptor antagonist and beta2 adrenergi...

Compounds having muscarinic receptor antagonist and BETA2 adrenergi...

Compounds having muscarinic receptor antagonist and beta2 adrenergi...

Fused pyrazine compounds useful for the treatment of degenerative a...

Imidazolopyrazine compounds useful for the treatment of degenerativ...

Imidazolopyrazine compounds useful for the treatment of degenerativ...

Fused pyrazine compounds useful for the treatment of degenerative a...

Fused pyrazine compounds useful for the treatment of degenerative a...

Fused pyrazine compounds useful for the treatment of degenerative a...

Triazolopyridine compounds useful for the treatment of degenerative...

Triazolopyrazine compounds useful for the treatment of degenerative...

Imidazolopyrazine compounds useful for the treatment of degenerativ...

Triazolopyrazine compounds useful for the treatment of degenerative...

Patents Applicationslast 30 patents

COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF

COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGI...

Fused Pyrazine Compounds Useful for the Treatment of Degenerative a...

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIV...

TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE...

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIV...

TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE...

FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE A...

Fused pyrazine compounds useful for the treatment of degenerative a...

Triazolopyridine compounds useful for the treatment of degenerative...

Fused pyrazine compounds useful for the treatment of degenerative a...

Triazolopyrazine compounds useful for the treatment of degenerative...

Imidazolopyrazine compounds useful for the treatment of degenerativ...